Over the recent years, the treatment of multiple sclerosis (MS) and neuromyelitis optica
spectrum disorder (NMOSD) has evolved very rapidly and a large number of disease …

Progressive multifocal encephalopathy (PML) is a severe demyelinating disease of the
central nervous system (CNS) caused by JC virus (JCV), which occurs in …

Objective Progressive multifocal leukoencephalopathy (PML) is still burdened by high
mortality in a subset of patients, such as those affected by hematological malignancies. The …

Immunocompromised host section: Adoptive T-cell therapy for... : Current Opinion in
Infectious Diseases Immunocompromised host section: Adoptive T-cell therapy for dsDNA …

Progressive multifocal leukoencephalopathy (PML) is an opportunistic viral disease of the
brain—caused by human polyomavirus 2. It affects patients whose immune system is …

Objective Progressive multifocal leukoencephalopathy (PML) is a devastating demyelinating
opportunistic infection of the brain caused by the ubiquitously distributed JC polyomavirus …

Background The blood-cerebrospinal fluid (CSF) barrier (BCSFB) is critically important to the
pathophysiology of the central nervous system (CNS). However, this barrier prevents the …

Progressive multifocal leukoencephalopathy (PML) is a progressive and generally fatal
demyelinating neurologic disease that occurs in profoundly immunocompromised patients …

Adoptive immunotherapy with virus-specific cytotoxic T cells (VSTs) has evolved over the
last three decades as a strategy to rapidly restore virus-specific immunity to prevent or treat …

Objectives: Evaluation of the feasibility of SARS-CoV-2-specific T cell manufacturing for
adoptive T cell transfer in COVID-19 patients at risk to develop severe disease. Methods …